We’ve built our reputation on solving complex market access challenges for pharmaceutical, biotech, and device companies, with a strong focus on innovative therapies for rare diseases. Your market access challenges can’t be solved with a one-size-fits-all approach, which is why we craft bespoke pharma market access strategy and medical communications solutions that position you to win from the outset. Our curated network of expert consultants combines decades of experience with a passion for pushing past the status quo. Ready to supercharge your market access communications? Let's get writing.
| Website | http://www.stratenym.com/ |
| Employees | 25 (14 on RocketReach) |
| Founded | 2019 |
| Phone | +1 647-948-9087 |
| Technologies |
JavaScript
,
HTML
,
PHP
+24 more
(view full list)
|
| Industry | Business Consulting and Services |
| Keywords | Pharmaceutical Market Access, Biotech Market Access, Pricing And Reimbursement, Medical Device Market Access, Innovative Therapies, Market Access Consulting, Patient Access, Value Demonstration, Reimbursement Strategies, Market Access Strategy, Commercialization Strategy, Healthcare Consulting, Regulatory Affairs, Drug Development, Health Economics, Global Market Access |
| Competitors | Covalent, Nansen Limited, Glassnode, Santiment AG, Token Terminal, Chainalysis, Amberdata, Messari, DeFi Pulse, Alethio +31 more (view full list) |
Looking for a particular STRATENYM employee's phone or email?
Sabrina Smith is the Vice President and Co-Founder of STRATENYM.
14 people are employed at STRATENYM.